[PRLD] YoY Quarter Result on 30-Jun-2023 [#Q2]

Stock
[PRLD] Prelude Therapeutics Incorporated
Announcement Date
03-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -15.61%
YoY- -20.34%
Quarter Report
PRLD's Result
PRLD's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 CAGR
Revenue 0 0 0 0 0 0 -
PBT -34,740 -30,431 -27,374 -26,865 -11,408 -5,399 45.05%
Tax 0 239 -2,087 -290 0 0 -
NP -34,740 -30,431 -25,287 -26,865 -11,408 -5,399 45.05%
Tax Rate - - - - - - -
Total Cost 34,740 30,431 25,287 26,865 11,408 5,399 45.05%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 CAGR
EPS -0.46 -0.54 -0.53 -0.58 -0.30 -3.43 -33.06%
EPS Diluted -0.46 -0.54 -0.53 -0.58 -0.30 -3.42 -33.02%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.